Cited by 2,309interferon and immune responsesImmune Response and InflammationInflammasome and immune disorders

The cGAS–STING pathway as a therapeutic target in inflammatory diseases

Open access
Decout, Alexiane, Katz, Jason D., Venkatraman, Shankar, Ablasser, Andrea·2021·Nature Reviews Immunology

Abstract

The cGAS-STING signalling pathway has emerged as a key mediator of inflammation in the settings of infection, cellular stress and tissue damage. Underlying this broad involvement of the cGAS-STING pathway is its capacity to sense and regulate the cellular response towards microbial and host-derived DNAs, which serve as ubiquitous danger-associated molecules. Insights into the structural and molecular biology of the cGAS-STING pathway have enabled the development of selective small-molecule inhibitors with the potential to target the cGAS-STING axis in a number of inflammatory diseases in humans. Here, we outline the principal elements of the cGAS-STING signalling cascade and discuss the general mechanisms underlying the association of cGAS-STING activity with various autoinflammatory, autoimmune and degenerative diseases. Finally, we outline the chemical nature of recently developed cGAS and STING antagonists and summarize their potential clinical applications.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41577-021-00524-z

Cites

212 of 212 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intracellular cues such as retrotransposable elements (e.g., LINE-1), cytosolic mitochondrial DNA, and circular DNA can activate cGAS-STING and trigger pro-inflammatory genes weeks or months after senescence induction.

    “These include retrotransposable elements (for example, LINE-1), cytosolic mitochondrial DNA, or circular DNA—all of which can activate the cytosolic DNA-sensing (cGAS)-STING pathway, triggering the expression of pro-inflammatory genes79–81.”

    From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [81]

    The sections on cell-intrinsic genomic and mitochondrial DNA describe LINE-1-derived DNA and cytosolic mitochondrial DNA activating cGAS–STING. The senescence and ageing section links cGAS–STING activity to inflammatory secretions from senescent cells. Our copy does not establish circular DNA as one of these triggers or specify that pro-inflammatory genes are induced weeks or months after senescence induction (pages unavailable). (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • In 2008, the cGAS-STING DNA-sensing pathway was discovered as a vital mediator in detecting misplaced or foreign DNA and triggering release of type I interferons and other immune mediators.

    “In 2008, the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) DNA-sensing pathway has been discovered as a vital mediator in detecting the misplaced or foreign DNA and triggering the release of type I interferons and other immune mediators.388,389”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [388]

    The Introduction describes cGAS–STING as a critical mechanism for sensing foreign and self DNA, and the Overview says its activation induces type I interferons and other inflammatory mediators. The copy does not establish that the cGAS–STING pathway was discovered in 2008; its References identify a 2008 paper about STING specifically. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • cGAS can sense cytosolic DNA, allosterically activate its catalytic activity and induce synthesis of cGAMP.

    “cGAS can sense cytosolic DNA,390 allosterically activate its catalytic activity and induce the synthesis of second messenger molecule, 2′3′ cyclic GMP–AMP (cGAMP).388”

    From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [388]

  • The SASP is dynamic, changes over time, and varies with the type of senescent cell and how senescence was induced.

    “The SASP of senescent cells is not static; it can change over time78–80 and varies depending on the type of cells that became senescent and how senescence was induced16,44,59,60,81.”

    From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [81]

    The ‘cGAS–STING in senescence and ageing’ section describes SASP secretion and a role for cGAS–STING across multiple types of senescent cells. It does not say that the SASP changes over time or varies by cell type or how senescence was induced; searches for those distinctions found no supporting passage. (LLM, conf=0.74)

    Experimental — accuracy not yet measured
  • Senescence-associated DNA damage is sensed through the cGAS-STING pathway, which activates IRF3 and NF-κB and induces interferon and SASP responses.

    “Senescence-associated DNA damage is sensed via the cGAS–STING pathway, which activates the transcription factors interferon regulatory factor 3 (IRF3) and NF-κB, thereby inducing an interferon and SASP response55–58”

    From COVID-19 and cellular senescence (2023) · cites this paper as [58]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

3 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Decout, A., Katz, J. D., Venkatraman, S., & Ablasser, A.
Affiliations
  • École Polytechnique Fédérale de Lausanne (CH)
  • Ifm Therapeutics (United States) (US)
Corresponding author
Ablasser, Andrea
Venue
Nature Reviews Immunology
Published
2021-04-08
Volume
21
Issue
9
Pages
548-569
ISSN
  • 1474-1733 (ISSN-L)
  • 1474-1741
OpenAlex
W3145334405
Cited by
2,309
References
212
Citations by year
2026: 514 · 2025: 598 · 2024: 566 · 2023: 382 · 2022: 204 · 2021: 43 · 2020: 1
FWCI
30.77
Type
journal article
Language
en
Open access
Locations
  • Nature reviews. Immunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (159836, 31003A)
  • H2020 European Research Council (804933)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
cGAS-STING pathway, cytosolic DNA sensing, innate immunity, inflammatory diseases, autoimmune disease, autoinflammatory disease, degenerative diseases, small molecule inhibitors, damage-associated molecular patterns
MeSH terms
Gain of Function Mutation, Animals, Autophagy, DNA, Mitochondrial, Enzyme Inhibitors, Humans, Inflammation, Membrane Proteins, Models, Biological, Models, Molecular, Nucleotides, Cyclic, Nucleotidyltransferases, Signal Transduction, Cell Death, Inflammation Mediators, Adaptor Proteins, Signal Transducing, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review